# Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer

> **NCT04027764** · PHASE2 · UNKNOWN · sponsor: **Dai, Guanghai** · enrollment: 30 (estimated)

## Conditions studied

- Advanced Biliary Tract Cancer

## Interventions

- **DRUG:** Toripalimab Combined With S1 and Albumin Paclitaxel

## Key facts

- **NCT ID:** NCT04027764
- **Lead sponsor:** Dai, Guanghai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-01
- **Primary completion:** 2020-05-01
- **Final completion:** 2021-05-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04027764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04027764, "Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04027764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*